FDA Inspection 1013543 — South Florida Institute for Reproductive Medicine
The FDA completed an inspection of South Florida Institute for Reproductive Medicine on March 16, 2017 in Jupiter, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 16, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Jupiter, FL (United States)